Daniela Barros‐Silva

Author

Instituto Português de Oncologia Francisco Gentil ORCID

Also Known As

Barros-Silva, Daniela, D. Barros-Silva, DANIELA BARROS-SILVA, Daniela Barros-Silva, Daniela Barros‐Silva

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Instituto Português de Oncologia Francisco Gentil Universidade do Porto IPO Porto Rede de Química e Tecnologia Princess Máxima Center

About

Daniela Barros‐Silva is an author at Instituto Português de Oncologia Francisco Gentil specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	128
2	Cell Biology	2	2	46
3	Engineering	1	1	15
4	Natural Sciences	1	1	15
5	Biostatistics	1	1	15

Daniela Barros‐Silva

Publications

818

Citations

H-Index

Page 1

	Year	Citations
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine Ana Rita Lima, Joana Pinto, Ana Isabel Azevedo, British Journal of Cancer	2019	109
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction David Bidarra, Vera Constâncio, Daniela Barros‐Silva, Frontiers in Oncology	2019	95
VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer Daniela Barros‐Silva, João Lobo, Catarina Guimarães‐Teixeira, Cancers	2020	85
Germ cell tumour subtypes display differential expression of microRNA371a-3p Bárbara Vilela-Salgueiro, Daniela Barros‐Silva, João Lobo, Philosophical Transactions of the Royal Society B Biological Sciences	2018	59
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis Daniela Barros‐Silva, Pedro Costa‐Pinheiro, Henrique O. Duarte, Cell Death and Disease	2018	57
MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples Gonçalo Outeiro-Pinho, Daniela Barros‐Silva, Elena Aznar, Journal of Experimental & Clinical Cancer Research	2020	55
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors Vera Miranda‐Gonçalves, João Lobo, Catarina Guimarães‐Teixeira, Journal of Experimental & Clinical Cancer Research	2021	54
Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling Catarina Macedo‐Silva, Vera Miranda‐Gonçalves, Nuno Tiago Tavares, Signal Transduction and Targeted Therapy	2023	46
New findings on urinary prostate cancer metabolome through combined GC–MS and 1H NMR analytical platforms Ana Rita Lima, Joana Pinto, Daniela Barros‐Silva, Metabolomics UrologyNew FindingsGenitourinary CancerMedicineMass Spectrometry	2020	36
XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality João Lobo, Sandra P. Nunes, Ad Gillis, Cancers	2019	32

Page 1